糖尿病和接触性皮肤炎患者的医疗器械
J P Velasco-Amador1, Á Prados-Carmona1, F J Navarro-Triviño2
1Servicio de Dermatología. Hospital Universitario San Cecilio, Granada, Spain.
Actas dermo-sifiliograficas
|November 4, 2024
概括
糖尿病设备的接触性皮肤炎正在增加. 异波尼尔烯酸盐 (IBOA) 和其他粘合剂成分是关键的过敏原,需要皮肤科医生的参与和制造商的合作.
科学领域:
- 过敏和皮肤病学
- 生物医学工程 生物医学工程
- 内分泌学 在内分泌学.
背景情况:
- 通过葡萄糖传感器和胰岛素彻底改变了糖尿病管理.
- 越来越多的接触性皮肤炎报告与这些必要的医疗器械有关.
- 在设备粘合剂中识别敏感性过敏原是一个越来越令人担忧的问题.
研究的目的:
- 在使用连续葡萄糖传感器和胰岛素的用户中识别引起接触性皮肤炎的过敏原.
- 要突出对设备组件的过敏反应的流行和影响.
- 为皮肤科医生和内分泌学家提供有关当前和新兴过敏原的信息.
主要方法:
- 对与设备相关的接触性皮肤炎的临床病例和科学文献的审查.
- 特定的化学化合物的识别涉及作为过敏原.
- 对当前糖尿病技术中常见和新兴成分的分析.
主要成果:
- 在FreeStyle葡萄糖传感器中被确定为主要过敏原的伊索博尼尔烯酸盐 (IBOA),导致其被删除.
- 科洛芬,阿比酸衍生物,二乙烯糖醇二烯酸盐,N,N-二甲基胺和三乙烯糖醇甲基酸盐也是涉及的过敏原.
- 一些已识别的过敏原仍在广泛使用的设备中使用,造成持续的风险.
结论:
- 过敏接触性皮肤炎对糖尿病设备组件的过敏会显著影响患者的生活质量和治疗坚持.
- 皮肤科医生在管理这些反应,指导患者护理和与制造商合作方面至关重要.
- 需要对新发现的过敏原进行进一步的研究和临床测试,以确保患者的安全性和设备的有效性.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
508
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
508
Pathophysiology of Diabetes
872
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
872
Skin Diseases and Disorders
3.6K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.6K
Diabetes: Management and Pharmacotherapy
236
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
236


